Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China
· Delayed Price · Currency is CNY 18.62
+0.24 (1.31%)
Mar 10, 2026, 2:04 PM CST
SHE:002932 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,034 | 4,103 | 5,341 | 8,945 | 7,761 | 4,350 | Upgrade
|
| Market Cap Growth | -2.11% | -23.18% | -40.29% | 15.26% | 78.41% | 80.42% | Upgrade
|
| Enterprise Value | 460 | 3,795 | 3,388 | 6,198 | 6,696 | 3,786 | Upgrade
|
| Last Close Price | 18.38 | 17.35 | 21.48 | 33.25 | 27.35 | 15.95 | Upgrade
|
| PE Ratio | 568.40 | 55.06 | 71.28 | 2.13 | 5.49 | 9.28 | Upgrade
|
| PS Ratio | 11.48 | 11.72 | 7.13 | 0.85 | 2.74 | 4.54 | Upgrade
|
| PB Ratio | 0.70 | 0.68 | 0.85 | 1.32 | 2.72 | 3.90 | Upgrade
|
| P/TBV Ratio | 0.73 | 0.71 | 0.89 | 1.38 | 2.80 | 4.01 | Upgrade
|
| P/FCF Ratio | - | - | 18.91 | 2.42 | 7.58 | 13.13 | Upgrade
|
| P/OCF Ratio | - | - | 13.61 | 2.23 | 6.89 | 12.09 | Upgrade
|
| EV/Sales Ratio | 1.31 | 10.84 | 4.52 | 0.59 | 2.37 | 3.95 | Upgrade
|
| EV/EBITDA Ratio | - | - | 57.13 | 1.20 | 3.93 | 6.74 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 1.21 | 3.98 | 6.95 | Upgrade
|
| EV/FCF Ratio | -3.02 | - | 11.99 | 1.68 | 6.54 | 11.43 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.03 | 0.02 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.64 | 0.04 | 0.03 | 0.25 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.17 | 0.06 | 0.04 | 0.43 | Upgrade
|
| Net Debt / Equity Ratio | -0.65 | -0.21 | -0.17 | -0.65 | -0.65 | -0.65 | Upgrade
|
| Net Debt / EBITDA Ratio | 17.56 | 14.38 | -18.37 | -0.84 | -1.08 | -1.29 | Upgrade
|
| Net Debt / FCF Ratio | 24.54 | 4.76 | -3.85 | -1.18 | -1.80 | -2.20 | Upgrade
|
| Asset Turnover | 0.05 | 0.05 | 0.09 | 1.67 | 1.17 | 0.93 | Upgrade
|
| Inventory Turnover | 2.37 | 2.06 | 1.60 | 14.70 | 3.52 | 2.68 | Upgrade
|
| Quick Ratio | 14.86 | 4.32 | 2.42 | 3.10 | 4.84 | 3.42 | Upgrade
|
| Current Ratio | 15.95 | 4.84 | 2.70 | 3.25 | 5.50 | 3.94 | Upgrade
|
| Return on Equity (ROE) | -0.81% | 0.43% | 1.06% | 91.05% | 72.97% | 54.97% | Upgrade
|
| Return on Assets (ROA) | -2.54% | -1.31% | -0.05% | 50.90% | 43.43% | 32.96% | Upgrade
|
| Return on Invested Capital (ROIC) | -13.09% | -2.41% | -0.09% | 260.54% | 206.48% | 120.24% | Upgrade
|
| Return on Capital Employed (ROCE) | -4.50% | -2.40% | -0.10% | 75.20% | 58.60% | 48.70% | Upgrade
|
| Earnings Yield | 0.18% | 1.82% | 1.40% | 47.05% | 18.21% | 10.78% | Upgrade
|
| FCF Yield | -3.78% | -6.58% | 5.29% | 41.36% | 13.19% | 7.62% | Upgrade
|
| Dividend Yield | 6.49% | 7.09% | 0.56% | 10.50% | 7.41% | 4.04% | Upgrade
|
| Payout Ratio | 3986.62% | 63.59% | 777.41% | 13.08% | 20.05% | 1.80% | Upgrade
|
| Buyback Yield / Dilution | 4.65% | 0.54% | 1.22% | -8.61% | -1.43% | -0.23% | Upgrade
|
| Total Shareholder Return | 11.14% | 7.63% | 1.78% | 1.89% | 5.98% | 3.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.